I agree that this site is using cookies. You can find further informations here.
X
Lishchinskaya, A A
49  results:
Search for persons X
?
1

P338 The dependence of the level of Glycoprotein type 2 on ..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A.
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i731-i731 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P273 The duration of clinical remission in patients with Cr..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S306-S306 , 2021
Link: https://doi.org/10.1093/..
 
?
3

Loss of response and frequency of adverse events in patient..:

Knyazev, O. V. ; Zvyaglova, M. Yu. ; Kagramanova, A. V....
Terapevticheskii arkhiv.  93 (2021)  2 - p. 150-157 , 2021
Link: https://doi.org/10.26442..
 
?
4

P359 Influence of the nature of immunosuppressive therapy i..:

Knyazev, O ; Kagramanova, A ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S379-S379 , 2021
Link: https://doi.org/10.1093/..
 
?
5

P320 Combined mesenchymal stromal cells and anti-cytokine t..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S346-S347 , 2021
Link: https://doi.org/10.1093/..
 
?
6

P243 Elevated presepsin levels are a marker of sepsis risk ..:

Knyazev, O ; Kagramanova, A ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S286-S287 , 2021
Link: https://doi.org/10.1093/..
 
?
7

P270 Mesenchymal stromal cells contribute to the recovery o..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S304-S304 , 2021
Link: https://doi.org/10.1093/..
 
?
8

P617 Mesenchymal stromal cells of bone marrow reduce the ri..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A.
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S513-S514 , 2020
Link: https://doi.org/10.1093/..
 
?
9

P592 Frequency and causes of prolongation of the induction ..:

Knyazev, O ; Kagramanova, A ; Lishchinskaya, A.
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S494-S494 , 2020
Link: https://doi.org/10.1093/..
 
?
10

DOP77 The effectiveness of combination therapy mesenchymal ..:

Knyazev, O ; Kagramanova, A ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S076-S077 , 2019
Link: https://doi.org/10.1093/..
 
?
11

Evaluation of efficacy and comparative frequency of adverse..:

Knyazev, O V ; Shkurko, T V ; Kagramanova, A V...
Terapevticheskii arkhiv.  91 (2019)  8 - p. 41-46 , 2019
Link: https://doi.org/10.26442..
 
?
12

P179 Changes in the haemostatic system in patients with ulc..:

Knyazev, O ; Kagramanova, A ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S178-S179 , 2019
Link: https://doi.org/10.1093/..
 
?
13

P413 Relative frequency of relapses in patients with ulcera..:

Fadeeva, N ; Knyazev, O ; Kagramanova, A...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S313-S313 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Efficacy and tolerability of certolizumab pegol in Crohn's ..:

Knyazev, O V ; Kagramanova, A V ; Lishchinskaya, A A...
Terapevticheskii arkhiv.  90 (2018)  6 - p. 74-80 , 2018
Link: https://doi.org/10.26442..
 
?
15

DOP058 Combined stem cells and anticytokine therapy contrib..:

Fadeeva, N ; Knyazev, O ; Kagramanova, A...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S071-S071 , 2018
Link: https://doi.org/10.1093/..
 
1-15